Related Experiment Video
Updated: May 7, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Reintervention for Acute Aortic Prosthesis Endocarditis: Early and Mid-Term Outcomes
Michele D'Alonzo1,2, Yuthiline Chabry1,2, Giovanna Melica3
1Service de Chirurgie Cardiaque, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France.
Redo surgery for acute infective endocarditis after aortic valve replacement has high early mortality but offers acceptable 5-year survival. These complex procedures for prosthetic valve endocarditis require careful management.
Area of Science:
- Cardiology
- Cardiac Surgery
- Infectious Diseases
Background:
- Acute infective endocarditis requiring aortic valve replacement presents significant surgical challenges.
- Redo procedures for prosthetic valve endocarditis carry high risks, with limited options for valve-in-valve interventions.
- Surgical management often involves complex procedures with increased morbidity and mortality.
Purpose of the Study:
- To analyze outcomes and challenges of surgical redo procedures for acute infective endocarditis post-aortic valve replacement.
- To evaluate early and late mortality, complications, and major adverse cardiac and cerebrovascular events (MACCEs) in these patients.
Main Methods:
- Retrospective, monocentric, observational study.
- Inclusion of 54 patients who underwent surgical re-operation for infective endocarditis between 2016 and 2023.
- Analysis of endpoints including mortality, complications, and MACCEs.
Main Results:
- Isolated aortic valve replacement was feasible in 63% of cases; complex procedures were needed for others.
- The 30-day mortality rate was 18.5%, with 9.3% requiring post-operative extracorporeal membrane oxygenation (ECMO) and 2.7% experiencing a new stroke.
- Five-year overall survival was 58.3%, and freedom from MACCEs was 41.7%.
Conclusions:
- Redo surgery for acute infective endocarditis remains a high-risk intervention with significant early mortality.
- Despite risks, the 5-year survival rate suggests a relatively acceptable long-term outcome.
- Managing prosthetic valve endocarditis surgically is complex and requires specialized care.
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Aneurysm III: Interprofessional Care

